Learn More
TARGETMOL CHEMICALS INC BIMIRALISIB 10MG

Supplier: TARGETMOL CHEMICALS INC T2265

Also available in 1 mg 2 mg 5 mg 25 mg 50 mg 100 mg 500 mg and bulk. Please contact Fisher for quotes. Bimiralisib (PI3K-IN-2) is an orally bioavailable pan inhibitor of PI3K and inhibitor of the mTOR with potential antineoplastic activity. PI3K-IN-2 inhibits the PI3K kinase isoforms alpha beta gamma and delta and to a lesser extent mTOR kinase which may result in tumor cell apoptosis and growth inhibition in cells overexpressing PI3K/mTOR. Activation of the PI3K/mTOR pathway promotes cell growth survival and resistance to both chemotherapy and radiotherapy. purity: 99%
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.